Novel Virtual Workshop to Improve HPV and Oropharyngeal Cancer Knowledge Among Interprofessional Students and Trainees

Presentation: P600
Topic: Oropharynx / HPV Related Disease
Type: Poster
Authors: Shaghauyegh S Azar, BS; Lauran K Evans, MD, MPH; Brooke M Su-Velez, MD, MPH; Maie A St. John, MD, PhD
Institution(s): Department of Head and Neck Surgery, University of California Los Angeles


: Human papillomavirus (HPV) and its associated malignancies represent a large and changing burden of disease around the world, and recommendations for HPV vaccination in the adult population are currently a dynamic topic of discussion. Awareness of HPV’s role in the development of head and neck cancer (HNC) has been demonstrated to be low among students and trainees, in an era of low vaccination rates against HPV and the rising epidemic of HPV-related HNC. A previous in-person HPV educational workshop was shown to successfully improve HPV knowledge and attitudes regarding HPV vaccination among medical students. The objective herein is to improve knowledge regarding HPV, HPV-related HNC, and the role of vaccination through an interprofessional workshop for primary care resident physicians, and to evaluate the efficacy of this approach.


: A previous in-person HPV educational workshop we developed was adapted for the resident level, using a virtual online platform. Surveys were distributed to primary care residents immediately before, and 1-2 weeks after the implementation of the 1-hour interactive virtual HPV workshop, which was led by otolaryngologists. Surveys included knowledge based and attitude questions to assess the workshop’s impact on improving resident knowledge of HPV and changes in provider vaccination practices.


: Preliminary pre-survey results from 43 participants (family medicine and internal medicine) indicate 60% were themselves vaccinated against HPV, and 70% believed HPV vaccination should be mandatory. Respondents preliminarily demonstrated increased knowledge in areas pertaining to HPV after the intervention, such as the risk of salivary transmission (33% to 75%) and recent approval of the HPV vaccine for prevention of head and neck cancer (63% to 93%). 93% of physicians believed that the workshop changed their HPV vaccination practices, 91% reported an increase in likelihood of getting vaccinated themselves after the workshop, and 93% stated that they are now likely to recommend the vaccine to patients between the ages of 27 and 45.


An interactive virtual workshop developed by the authors has demonstrated improved HPV-related knowledge and provider vaccination attitudes among primary care residents and can continue to be adapted for multi-disciplinary curriculum settings. This course serves to foster an interprofessional understanding of the role of HPV in HNC and subsequently strengthen recommendations for HPV vaccination. This workshop is now available in a virtual format and can be shared with trainees and colleagues in multiple specialties all across the globe, thus improving prevention and screening for all patients with HPV-related disease.